Search clinical trials for: pravastatin, rosuvastatin

Total 886 results

University Hospital, Motol

Unknown

Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study (TIPS-3)

Coronary Artery Disease

Czech Republic, Slovakia
Beijing Anzhen Hospital

Unknown

Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS (AVATAR)

Acute Coronary Syndrome | Angioplasty

China
AstraZeneca

Completed

Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks (POLARIS)

Hypercholesterolemia | Coronary Heart Disease
AstraZeneca

Completed

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) (IRIS)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.

Hypercholesterolaemia
Makerere University
University of Oxford; Case Western Reserve University

Unknown

Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial (STAR)

HIV Infection
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Colorectal Cancer | Precancerous Condition

United States, Canada
University of Erlangen-Nürnberg Medical School
AstraZeneca

Completed

Rosuvastatin and Renal Endothelial Function

Hypercholesterolemia

Germany
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

Healthy

United Kingdom
G. d'Annunzio University
Working Group Aterosclerosi, Trombosi e Biologia Vascolare

Terminated

Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty (REMEDY)

Stable Coronary Artery Disease Undergoing PCI

Italy
AstraZeneca

Withdrawn

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis (Du Lac)

Venous Thrombosis | Pulmonary Embolism
GlaxoSmithKline

Completed

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Infection, Human Immunodeficiency Virus

United States
University of British Columbia
AstraZeneca; CIHR Canadian HIV Trials Network

Terminated

Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients

HIV Infections | Atherosclerosis

Canada
Pomeranian Medical University Szczecin

Completed

Statins in Patients With Spontaneous Intracerebral Hemorrhage

Intracerebral Hemorrhage

Poland
Bristol-Myers Squibb

Completed

Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants

Healthy Participants

United States
Chang Gung Memorial Hospital

Completed

The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome

Sleep Apnea, Obstructive

Taiwan
Bayer

Completed

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate

Healthy Volunteers | Pharmacokinetics | Drug Interaction

Germany
LG Life Sciences

Unknown

BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone

Healthy

Korea, Republic of
Alvogen Korea

Completed

A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

Healthy Volunteers
AstraZeneca

Completed

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe (GRAVITY)

Atherosclerosis | Hypercholesterolemia | Coronary Heart Disease

Chile, Argentina, Brazil, United States, Colombia, Lithuania, Netherlands, Peru, Venezuela
AstraZeneca

Completed

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Dyslipidaemia
Purdue University

Unknown

Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?

Physical Inactivity | Nonfamilial Hypercholesterolemia

United States
Juntendo University
Kumamoto University; Tokyo University; Kyoto University; Tohoku University; Yamaguchi...

Completed

Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

Coronary Artery Disease

Japan
SWOG Cancer Research Network
National Cancer Institute (NCI)

Completed

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
Aligos Therapeutics

Active, not recruiting

A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

Healthy Volunteers

United States
National Cancer Institute, Egypt

Completed

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Prostate Cancer Metastatic

Egypt
Radboud University Medical Center
AstraZeneca; Abbott

Completed

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

HIV Infections | Hyperlipidemia

Germany, Netherlands
Shenyang Northern Hospital

Withdrawn

A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI (TRACK-AMI)

ST Elevation Myocardial Infarction | Hydration | Contrast-induced Acute Kidney Injury | Primary PCI | Rosuvastatin

China
Resverlogix Corp
South Australian Health and Medical Research Institute

Terminated

Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

Coronary Artery Disease | Dyslipidemia

Australia
Gachon University Gil Medical Center

Completed

Vascular and Metabolic Effects of Rosuvastatin

Hypercholesterolemia

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients

Hypercholesterolemia

Korea, Republic of
AstraZeneca

Completed

Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib (Statin DDI)

Rheumatoid Arthritis

United States
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

Adverse Events | Pharmacokinetic Variables

United States
AstraZeneca

Completed

ROMEO (Rosuvastatin in Metabolic syndrOme)

Metabolic Syndrome X

Korea, Republic of
AstraZeneca

Completed

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

Hypercholesterolemia

Netherlands
Fred Hutchinson Cancer Center

Completed

Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

Leukemia

United States
Leiden University Medical Center
Amgen

Recruiting

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Aneurysmal Bone Cysts | Giant Cell Granuloma | Osteoblastoma | Chondroblastoma | Chondromyxoid Fibroma

France, Italy, Netherlands
Wake Forest University Health Sciences

Completed

EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) (EMERALD)

Lipid Disorder

United States
Chinese University of Hong Kong

Withdrawn

PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis

Atherosclerosis | Psoriatic Arthritis

Hong Kong
Pfizer
Arvinas Estrogen Receptor, Inc.

Completed

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults

Healthy

United States
GlaxoSmithKline

Completed

A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin

Asthma

United Kingdom
AstraZeneca

Completed

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

Healthy

United States
AstraZeneca

Withdrawn

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Primary Hypercholesterolaemia
AstraZeneca

Completed

Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) (ARIES)

Hypercholesterolemia | Dyslipidaemia
AstraZeneca

Completed

COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

Metabolic Syndrome
AstraZeneca
Mexican National Institute of Public Health

Completed

C-Reactive Protein (CRP) in Obese Diabetic Women

Diabetes Mellitus, Type 2

Mexico
Organon and Co

Completed

Evaluation of Ezetimibe and Atorvastatin Coadministration Versus Atorvastatin or Rosuvastatin Monotherapy in Japanese Patients With Hypercholesterolemia (Study P06027)(COMPLETED)

Primary Hypercholesterolemia
Government Dental College and Research Institute...

Completed

Rosuvastatin Gel With 1:1 Mixture of Platelet-rich Fibrin and Bone Graft in Mandibular Degree II Furcation Defects

Furcation Defects
AstraZeneca
The Cleveland Clinic

Completed

CRESTOR Athero Imaging Head to Head IVUS Study (SATURN)

Coronary Atherosclerosis

United States, France, Italy, Mexico, Russian Federation, Poland, Netherlands, Canada, Argentina, Australia, Belgium, Hungary, Spain, Brazil
AstraZeneca

Completed

PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin

Familial Hypercholesterolemia

United States, Spain, Netherlands, Norway, Canada

3

Subscribe